m7G modification affects the cellular composition of the immune microenvironment in ovarian cancer, and two key m7G modification-regulated genes, DCP2 and NUDT16, promotes the proliferation and metastases of ovarian cancer cells, and its high expression is associated with poor prognosis. This evidence concerns the gene NUDT16 and ovarian carcinoma.